Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1994 1
1996 1
2006 1
2007 1
2010 2
2012 3
2013 1
2014 1
2016 1
2017 3
2018 3
2019 2
2020 4
2021 4
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune Hypophysitis in Systemic Lupus Erythematosus.
Kapur S, Oswal J, Jahagirdar R, Viswanathan V. Kapur S, et al. Among authors: jahagirdar r. Indian Pediatr. 2021 Jan 15;58(1):84-85. Indian Pediatr. 2021. PMID: 33452786 Free article. No abstract available.
Field Testing of IAP2015 Charts.
Lohiya N, Khadilkar V, Pawar S, Khadilkar A, Chiplonkar S, Jahagirdar R. Lohiya N, et al. Among authors: jahagirdar r. Indian J Pediatr. 2018 Sep;85(9):723-728. doi: 10.1007/s12098-018-2621-4. Epub 2018 Jan 24. Indian J Pediatr. 2018. PMID: 29368106
Epigenetic BET reader inhibitor apabetalone (RVX-208) counters proinflammatory aortic gene expression in a diet induced obesity mouse model and in human endothelial cells.
Wasiak S, Tsujikawa LM, Daze E, Gilham D, Stotz SC, Rakai BD, Sarsons CD, Fu L, Azhar S, Jahagirdar R, Sweeney M, Johansson JO, Wong NCW, Kulikowski E. Wasiak S, et al. Among authors: jahagirdar r. Atherosclerosis. 2023 Jan;364:10-19. doi: 10.1016/j.atherosclerosis.2022.11.015. Epub 2022 Nov 23. Atherosclerosis. 2023. PMID: 36455344
Surgical obstructive jaundice.
Nadkarni KM, Jahagirdar RR, Kagzi RS, Pinto AC, Bhalerao RA. Nadkarni KM, et al. Among authors: jahagirdar rr. J Postgrad Med. 1981 Jan;27(1):33-9. J Postgrad Med. 1981. PMID: 7230073 Free article. No abstract available.
Apabetalone downregulates factors and pathways associated with vascular calcification.
Gilham D, Tsujikawa LM, Sarsons CD, Halliday C, Wasiak S, Stotz SC, Jahagirdar R, Sweeney M, Johansson JO, Wong NCW, Kalantar-Zadeh K, Kulikowski E. Gilham D, et al. Among authors: jahagirdar r. Atherosclerosis. 2019 Jan;280:75-84. doi: 10.1016/j.atherosclerosis.2018.11.002. Epub 2018 Nov 14. Atherosclerosis. 2019. PMID: 30476723 Free article.
Benefit of Apabetalone on Plasma Proteins in Renal Disease.
Wasiak S, Tsujikawa LM, Halliday C, Stotz SC, Gilham D, Jahagirdar R, Kalantar-Zadeh K, Robson R, Sweeney M, Johansson JO, Wong NC, Kulikowski E. Wasiak S, et al. Among authors: jahagirdar r. Kidney Int Rep. 2017 Dec 8;3(3):711-721. doi: 10.1016/j.ekir.2017.12.001. eCollection 2018 May. Kidney Int Rep. 2017. PMID: 29854980 Free PMC article.
The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation in vitro and in a mouse model of systemic inflammation.
Wasiak S, Fu L, Daze E, Gilham D, Rakai BD, Stotz SC, Tsujikawa LM, Sarsons CD, Studer D, Rinker KD, Jahagirdar R, Wong NCW, Sweeney M, Johansson JO, Kulikowski E. Wasiak S, et al. Among authors: jahagirdar r. Transl Neurosci. 2023 Dec 31;14(1):20220332. doi: 10.1515/tnsci-2022-0332. eCollection 2023 Jan 1. Transl Neurosci. 2023. PMID: 38222824 Free PMC article.
Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Van der Feen DE, Kurakula K, Tremblay E, Boucherat O, Bossers GPL, Szulcek R, Bourgeois A, Lampron MC, Habbout K, Martineau S, Paulin R, Kulikowski E, Jahagirdar R, Schalij I, Bogaard HJ, Bartelds B, Provencher S, Berger RMF, Bonnet S, Goumans MJ. Van der Feen DE, et al. Among authors: jahagirdar r. Am J Respir Crit Care Med. 2019 Oct 1;200(7):910-920. doi: 10.1164/rccm.201812-2275OC. Am J Respir Crit Care Med. 2019. PMID: 31042405
Immunogenicity and safety of Mebella™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study.
Krishna Susarla S, Jahagirdar R, Ghosh Uttam K, Srikanth Bhatt S, Prashanth S, Rajapantula V, Satish M, Rajashakar BC, Sandhya G, Rajendra L, Prasad Sahoo D, Kumar Kanakasapapathy A. Krishna Susarla S, et al. Among authors: jahagirdar r. Vaccine. 2023 Oct 20;41(44):6558-6564. doi: 10.1016/j.vaccine.2023.08.065. Epub 2023 Aug 31. Vaccine. 2023. PMID: 37659893
29 results